Growth hormone (GN) insensitivity is associated with several different muta
tions of the GN receptor gene and a recently described nov genetic disorder
of the IFGI gene. rile phenotype and biochemical characteristics were stud
ied in 82 patients with growth hormone insensitivity, fi-om 23 different co
untries, with a mean age of 8.25 years. Mean height SDS was -6.09, SDS of t
he ICF binding protein -3 (IGF BP3) was 7.99 Twenty three per cent of the p
atients Here GH binding protein (GHBP) positive (>10 %). Mean height SDS sc
ore was -6.5 in the GHBP negative patients and -4.9 in the GHBP positive pa
tients (p < 0.001). Fifteen different,mutations of the GH receptor gene wer
e identified in 27 patients There were no relationships between the type of
mutation or the involved GH receptor gene exon and height or IGFBP-3 SDS.
The new phenotype due to a partial deletion of the IGFI gene Ic ns describe
d in a 15-year-old boy who presented with a severe intrauterine growth reta
rdation, a very poor postnatal statural growth, a neurosensorial deafness a
nd a mild mental retardation. He had elevated GH In els, normal levels of I
GFBP3, undetectable levels of IGFI, and showed no response in GH treatment.
A partial deletion concerning the exons 4 and 5 of the IGFI gene was found
, Thus, GH insensitivity is associated with large variations in the clinica
l and biochemical phenotypes. (C) 1998 Elsevier, Paris.